Blood group MN-dependent difference in degree of galactosylation of O-glycans of glycophorinA is restricted to the GalNAc residues located on amino acid residues 2–4 of the glycophorin polypeptide chain
		1Dedicated to Professor Hans Paulsen on the occasion of his 75th birthday.1  by Krotkiewski, Hubert et al.
FEBS Letters 406 (1997) 296-300 FEBS 18429 
Blood group MN-dependent difference in degree of galactosylation of 
O-glycans of glycophorin A is restricted to the GalNAc residues located 
on amino acid residues 2-4 of the glycophorin polypeptide chain 
Hubert Krotkiewskia, Maria Duka, Danuta Sypera, Halina Lisb, Nathan Sharonb, 
Elwira Lisowskaa* 
aDepartment of Immunochemistry, Ludwik Hirszfeld Institute of Immunology and Experimental Therapy, Polish Academy of Sciences, 
Rudolf Weigl Street 12, 53-114 Wroclaw, Poland 
bDepartment of Membrane Research and Biophysics, The Weizmann Institute of Science, Rehovot 76100, Israel 
Received 3 February 1997; revised version received 26 February 1997 
Abstract Glycophorin A (GPA) of human erythrocytes con-
tains a minor number of unsubstituted GalNAc residues (Tn 
receptors) which are recognized by Moluccella laevis lectin 
(MLL). The lectin reacts better with blood group N- than M-
type of GPA which suggests a higher number of Tn receptors in 
GPA-N than in GPA-M. To find out whether this difference is 
restricted to a defined domain of GPA, the N-terminal tryptic 
glycopeptides of GPA-M and GPA-N (a.a. residues 1-39) and 
their fragments obtained by degradation with CNBr (a.a. 
residues 1-8 and 9-39) were analyzed. The untreated and 
desialylated glycopeptides were tested as inhibitors of MLL in 
ELISA, and the content of GalNAc-ol was determined in the 
products of ^-elimination of the asialoglycopeptides by gas-liquid 
chromatography/mass spectrometry. The asialoglycopeptides 1-
39 and 1-8 derived from GPA-N showed about 2 and 4 times 
higher content of non-galactosylated GalNAc residues, respec-
tively, and higher reactivity with MLL than their counterparts 
derived from GPA-M, while asialoglycopeptides 9-39 of GPA-
M and GPA-N did not show such differences. These results 
demonstrate that higher expression of non-galactosylated 
GalNAc in GPA-N than in GPA-M is confined to GalNAc 
residues located in the ammo-terminal portion of GPA polypep-
tide chain, between the blood group M- and N-specific amino 
acid residues 1 and 5. 
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1. Introduction 
Blood group M- and N-types of glycophorin A (GPA) 
of human erythrocytes differ in two amino acid residues 
(M: SerVGly5, N: LeuVGlu5). GPA carries one N-glycan 
on Asn26 and about 15 O-glycans. The major O-glycan is 
the tetrasaccharide NeuAca2-3Gaipi-3[NeuAca2-6]GalNAc-
which is accompanied by a minor number of other structures, 
due to microheterogeneity of glycosylation (for review see [1]). 
We have found previously that Moluccella laevis lectin 
(MLL), highly specific for iV-acetylgalactosamine [2-A], shows 
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anti-Tn (GalNAcod-Ser/Thr) specificity and reacts better with 
GPA-N than with GPA-M [5]. The interaction of GPA with 
MLL is increased and the difference between the reactivity of 
GPA-M and GPA-N is decreased after desialylation of GPA 
[5]. MLL is only weakly inhibited by galactose and the di-
saccharide Gal(31-3GalNAc ( = 500 times less than by Gal-
NAc) [3,5]. We have found that the contribution of Gaipi-
3GalNAc- chains of asialoGPA to its interaction with MLL is 
negligible and the lectin recognizes unsubstituted GalNAc res-
idues in GPA ([5], and unpublished results). Our results sug-
gested that GPA contains a minor number of non-galactosyl-
ated GalNAc residues, which are partly substituted by cc2-6-
linked /V-acetylneuraminic acid, and that number of these 
residues is higher in GPA-N than in GPA-M. This conclusion 
was confirmed by finding that Vicia villosa anti-Tn lectin 
(which does not react with native erythrocytes or GPA) also 
reacts more strongly with asialoGPA-N than asialoGPA-M 
[6]. Moreover, GalNAc-ol was identified in the products of 
(3-elimination of GPA (1 residue per several GPA molecules), 
its content was approximately 2 times higher in asialoGPA 
and was also higher in GPA-N and asialoGPA-N than in 
GPA-M and asialoGPA-M, respectively [7]. 
The above results suggested that efficiency of in vivo galac-
tosylation of GalNAc residues in GPA is modulated by amino 
acid residues at positions 1 and/or 5 which are different in 
GPA-M and GPA-N. That effect can be expected to be 
more pronounced in the proximity of these residues. The 
Ser/Thr residues of GPA are glycosylated at positions 2, 3 
and 4, and at several positions within amino acid residues 
10-50 of GPA polypeptide chain [8,9]. The aim of the experi-
ments described in this report was to examine whether the 
difference in galactosylation of GalNAc residues is restricted 
to positions 2-4 of GPA. It was done by analysis of various 
glycosylated fragments of GPA-M and GPA-N for the con-
tent of non-galactosylated GalNAc residues and for reactivity 
with MLL. 
2. Materials and methods 
2.1. GPA and its fragments 
GPA-M and GPA-N were purified from the membranes of out-
dated human blood group O, M and N erythrocytes, respectively 
[10]. Amino-terminal tryptic glycopeptides of GPA were obtained as 
described [11]. The glycopeptide fraction was a mixture of GPA frag-
ments containing a.a. residues 1-39 and 1-30/31 [8] and for simplicity 
is further designated as glycopeptide 1-39. Two fractions, containing 
glycopeptides 1-8 and 9-39, were obtained by CNBr-degradation of 
the glycopeptides 1-39 at Met8 [12]. The glycopeptides were desial-
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ylated by mild acid hydrolysis in 0.025 M sulfuric acid at 60°C for 4 h, 
neutralized with NaOH and repurifled by gel filtration on the Bio-Gel 
P-4 column. 
2.2. Analysis of carbohydrate composition 
The glycopeptides were hydrolyzed in 4 M trifluoroacetic acid at 
100°C for 4 h and monosaccharides were quantitated as alditol ace-
tates using a 5890 Hewlett-Packard gas chromatograph equipped with 
a mass spectrometer (GLC-MS). Xylose served as internal standard 
and an HP-1 capillary column (0.2 mmXl2 m) at a temperature 
gradient 150-230°C (8°/min) was used. 
2.3. The ^ -elimination and determination of GalNAc-ol 
The asialoglycopeptides were incubated in 0.05 M NaOH/1 M 
NaBH4 in the presence of Cd
2+ ions, according to the method of 
Likhosherstov et al. [13]. The reaction mixture was neutralized with 
50% acetic acid and supplemented with xylitol and perseitol as inter-
nal standards. The samples, dried in a rotary evaporator by co-evap-
oration with methanol and peracetylated with acetic anhydride in 
pyridine for 35 min at 100°C, were directly analyzed in a GLC-MS 
system [14], under the conditions described above. 
2.4. Affinity-purification of M. laevis lectin 
The PBS (20 mM phosphate buffer/0.15 M NaCl/0.02% sodium 
azide, pH 7.4) extract of ground and defatted M. laevis seeds (50 g) 
was obtained as described previously [3]. From 50 g seeds, 580 ml of 
the extract containing 4 g protein was obtained. CNBr-activated Se-
pharose 4B (Pharmacia, Uppsala, Sweden) (10 ml) was conjugated 
with asialoGPA-M (9.6 mg). The extract was applied in three portions 
to the asialoGPA-Sepharose column at a rate of 12 ml/h, and the 
column was washed with PBS until the absorbance of the effluent at 
280 nm was less than 0.1. The lectin, which was totally bound to the 
column, was eluted with 3 M KSCN and fractions (4 ml/15 min) 
giving absorption at 280 nm were pooled, dialyzed against PBS con-
taining 0.1 M galactose, and then against PBS. The precipitate formed 
was removed by centrifugation at 12 000Xg for 20 min and the super-
natant was concentrated by ultrafiltration. The yield (23 mg of lectin 
per 50 g of seeds) was similar to that obtained by previous method [3]. 
Analysis by SDS-polyacrylamide gel electrophoresis showed the typ-
ical pattern of MLL bands and no contamination. The lectin aggluti-
nated native and desialylated ON erythrocytes at concentrations of 15 
ug/ml and 0.5 u.g/ml, respectively. 
2.5. Lectin microtiter plate assays 
Inhibition of MLL with glycopeptides was tested using microtiter 
plates (Nunc, MaxiSorp, Vienna, Austria) coated with asialoGPA-N, 
and the bound lectin was revealed by rabbit anti-MLL antibodies and 
goat anti-rabbit Ig antibodies conjugated with alkaline phosphatase, 
as described earlier [5]. Inhibition of peanut agglutinin (PNA, Sigma, 
St. Louis, MO) was tested using the same method with biotinylated 
PNA and alkaline phosphatase-conjugated ExtrAvidin (Sigma). Lec-
tin biotinylation and details of the test were as described [15]. 
3. Results 
Glycopeptide 1-39 of PGA contains about 12 out of 15 
GPA O-glycans. As reported earlier, when this glycopeptide 
is derived from GPA-N it shows higher affinity for MLL than 
the corresponding peptide from GPA-M, while the tryptic 
glycopeptides 40-61 of GPA-M and GPA-N, carrying the 
remaining three O-glycans, show similar reactivity with 
MLL [5]. Therefore, we analyzed now only the glycopeptides 
1-39 and their fragments 1-8 and 9-39. 
Molar concentrations of glycopeptides in solutions were 
calculated from their carbohydrate composition, assuming 
that glycopeptides 1-39, 1-8 and 9-39 contain 12, 3 and 9 
O-glycans, respectively, and that glycopeptides 1-39 and 9-
39 contain one N-glycan. The validity of this assumption was 
confirmed by the results of inhibition of PNA binding to 
asialoGPA-coated ELISA plates. The asialoglycopeptides ob-
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Fig. 1. Inhibition of PNA binding to asialoGPA-coated ELISA 
plates with serially diluted asialoglycopeptides 1-39 (circles), 1-8 
(triangles) and 9-39 (diamonds), derived from GPA-M (full sym-
bols) and GPA-N (empty symbols). 
tained from GPA-M inhibited PNA almost identically as their 
counterparts from GPA-N (Fig. 1). 
All the glycopeptides tested inhibited MLL binding to asia-
loGPA-N-coated ELISA plates and desialylation of the gly-
copeptides increased markedly their inhibitory activity (Fig. 
2), in agreement with previous results [5]. Moreover, untreated 
glycopeptides 1-39 and 1-8 of GPA-N showed stronger inhib-
ition (3 and 4 times, respectively) than the respective glyco-
peptides of GPA-M, and this difference was lower, but still 
distinct ( ~ 2-fold) with the corresponding asialoglycopeptides 
(Fig. 2A,B). Glycopeptides 9-39 of GPA-M and GPA-N in-
hibited MLL similarly (Fig. 2C); the slightly higher activity of 
glycopeptide 9-39 from GPA-N most probably resulted from 
its contamination by undegraded glycopeptide 1-39, or glyco-
peptide 1-8. The concentrations of glycopeptides giving 50% 
inhibition of MLL and PNA are summarized in Table 1. 
GLC-MS analysis of the products of p-elimination was 
performed with asialoglycopeptides only, due to the low con-
tent of unsubstituted GalNAc and scarcity of material. A new 
method of analysis [14] was used, which differed from the 
previous method [7] in that the products of P-elimination 
were not fractionated by gel filtration, but the sample was 
directly peracetylated and applied to the gas chromatograph. 
Under the conditions used only monosaccharide alditols are 
detectable, and their possible partial loss during the frac-
tionation of P-elimination products is avoided. Two monosac-
charide alditols were detected, GalNAc-ol and Gal-ol (exam-
ple of analysis is shown in Fig. 3). Identification of these 
components was based on their retention times in GLC and 
on mass spectra which were typical for peracetylated alditols 
of these monosugars and were described elsewhere [16]. The 
content of GalNAc-ol was generally low in all asialoglycopep-
tides ( < 1 residue per molecule), and was similar in GPA-M 
and GPA-N derived glycopeptides 9-39. On the other hand, 
the content of GalNAc-ol was more than 2 times higher in 
GPA-N asialoglycopeptide 1-39 and 4 times higher in asialo-
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Fig. 2. Inhibition of MLL binding to asialoGPA-N-coated ELISA 
plates by serially diluted untreated (M, N, circles) and desialylated 
(asM, asN, diamonds) glycopeptides 1-39 (A), 1-8 (B) and 9-39 (C) 
obtained from GPA-M (full symbols) and GPA-N (empty symbols). 
glycopeptide 1-8 than in the respective GPA-M fragments 
(Table 2). The content of Gal-ol was higher than that of 
GalNAc-ol and did not show blood group MN-dependent 
differences. Gal-ol was also detected earlier in (3-elimination 
products of GPA [7,17] and its origin is not clear. 
4. Discussion 
In earlier studies free GalNAc-ol and NeuAcoc2-6GalNAc-
ol were either detected as minor components of (3-elimination 
products of glycophorins [18,19], or were not detected at all 
[17,20]. They may have escaped detection due to low content 
or/and loss during the fractionation of released oligosacchar-
ides. A minor amount of Tn receptors in asialoglycophorins 
was also detected by means of natural human anti-Tn anti-
bodies [21]. Our previous results [7], together with the present 
ones, confirm the existence of non-galactosylated GalNAc 
residues in GPA and show that their level is significantly high-
er in GPA-N vs. GPA-M. Moreover, we report now that the 
difference in the content of non-galactosylated GalNAc resi-
dues between GPA-M and GPA-N is localized in the amino-
terminal fragment of GPA, containing amino acid residues 1-
8 (which include blood group MN-specific amino acid resi-
dues 1 and 5) and three O-glycosidic chains linked to Ser2, 
Thr3 and Thr4. The differences in the content of GalNAc 
residues are well correlated with reactivity of glycopeptides 
with MLL. Only the glycopeptides 1-39 and 1-8 derived 
from GPA-N showed higher reactivity with MLL than respec-
tive GPA-M-derived glycopeptides. 
The results of MLL inhibition assays show that the activity 
of untreated GPA [5] and GPA-derived glycopeptides (Table 
1) is over 10 times lower than activity of their desialylated 
counterparts, despite our earlier finding [7] that only approx-
imately half of the non-galactosylated GalNAc residues is 
sialylated. It shows that in addition to partial sialylation of 
GalNAc residues, sialic acid residues present on adjacent oli-
gosaccharide chains may partly block access of unsubstituted 
GalNAc residues. On the other hand, the differences in the 
inhibitory activity of GPA-M vs. GPA-N are usually higher 
(over 15-fold) [5] than those found for blood group M and N 
glycopeptides (3-4-fold, Table 1). Most likely, in aggregated 
GPA only some most exposed Tn receptors (which include 
those dependent on blood group N) are available for MLL, 
while in non-aggregated M and N glycopeptides all GalNAc 
residues can react. This conclusion is supported by our 
present results which show that blood group N-dependent 
decrease of GalNAc galactosylation is localized in the ami-
no-terminal portion of GPA. Although the number of Tn 
receptors in GPA is low, MLL binds GalNAc strongly, with 
K& of 10
5-106 M _ 1 [4]. It may explain why MLL, in contrast 
to other anti-Tn lectins, detects these receptors on GPA and 
Table 1 
Concentrations of untreated and desialylated GPA glycopeptides 
giving 50% inhibition of MLL and PNA binding to asialo-GPA-N-
coated ELISA plates 
M, 1-39 
N, 1-39 
M, 1-8 
N, 1-8 
M, 9-39 
N, 9-39 
Native, MLL 
(nanomol/well) 
16.0 
5.3 
4.5 
1.2 
2.4 
1.9 
Asialo, MLL 
(nanomol/well) 
0.08 
0.04 
0.28 
0.14 
0.20 
0.17 
Asialo, PNA 
(nanomol/well) 
0.13 
0.14 
0.83 
1.00 
0.31 
0.30 
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Fig. 3. GLC-MS analysis of unhydrolyzed peracetylated P-elimination products of the glycopeptide 1-39 of GPA-N, containing internal stand-
ards (xylitol and perseitol). The upper part shows pattern of elution of xylitol, Gal-ol, GalNAc-ol and perseitol from GLC column. Peak with 
retention time 8.01 and other small peaks are non-carbohydrate components. In the lower part a mass spectrum of 11.87 peak (GalNAc-ol) is 
shown. 
why a small difference in the content of Tn receptors in GPA-
N vs. GPA-M is also distinctly detectable by MLL. 
In conclusion, our results demonstrate directly that differ-
ence in reactivity of GPA-M and GPA-N with MLL is due to 
the different content of non-galactosylated GalNAc residues 
(Tn receptors) in N-terminal fragments of GPA. The only 
reason for this difference is different amino acid residues in 
GPA-M and GPA-N. Modulation of GalNAc enzymatic gal-
actosylation by amino acid sequence of GalNAc-peptides has 
been demonstrated in model studies in vitro [22]. Our results 
show that such modulation occurs also in vivo and affects 
mainly GalNAc residues located in proximity of 'modulating' 
Table 2 
Content of GalNAc-ol and Gal-ol in the products of P-elimination 
of GPA-M and GPA-N glycopeptides 
M, 1-39 
N, 1-39 
M, 1-8 
N, 1-8 
M, 9-39 
N, 9-39 
GalNAc-ol 
mol/mol 
0.28 
0.62 
0.10 
0.38 
0.17 
0.22 
glycopeptide 
Gal-ol 
3.8 
3.2 
0.9 
0.7 
2.2 
2.8 
amino acid residues. A specific agglutination of blood group 
N erythrocytes by MLL is an example illustrating that even a 
subtle alteration of glycosylation resulting from amino acid 
replacements may distinctly influence glycosylation-dependent 
cellular interactions, e.g. by passing the threshold of cell sur-
face receptor density required for agglutination. 
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